IPP Bureau
Natco Pharma receives 8 observations from USFDA for Pharma Division at Kothur
By IPP Bureau - October 23, 2023
The company is confident of addressing all the observations within the stipulated time
Zhimeng Biopharma CB03 receives Orphan Drug Designation from the USFDA
By IPP Bureau - October 23, 2023
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
ERS Genomics completes licensing agreement with Syngene International
By IPP Bureau - October 23, 2023
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
India should take global leadership with Holistic Healthcare Approach: Sonowal
By IPP Bureau - October 23, 2023
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
KKR to invest in life sciences firm Catalio Capital Management
By IPP Bureau - October 23, 2023
Investment is additive to KKR’s existing health care growth strategy
LG Chem initiates phase 2 clinical trials in patients with defects in MC4R pathway causing obesity and hyperphagia
By IPP Bureau - October 23, 2023
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
FDA approves only vaccine Penbraya for treatment of meningococcal disease in adolescents
By IPP Bureau - October 21, 2023
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery
By IPP Bureau - October 21, 2023
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Aarti Drugs Q2 FY24 consolidated net profit drops QOQ to Rs. 39.59 Cr
By IPP Bureau - October 21, 2023
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr
By IPP Bureau - October 21, 2023
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
Mandaviya convenes meeting to reiterate the nation’s commitment to addressing gender inequality
By IPP Bureau - October 21, 2023
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
Global Hand Washing Day: Sir HN Reliance Foundation Hospital initiates awareness campaign for underprivileged students in Mumbai
By IPP Bureau - October 20, 2023
hey were educated about the 7- step hand-washing technique trainings
Granules India receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules
By IPP Bureau - October 20, 2023
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Need to include ASMD as a notified condition in the National Policy for rare diseases
By IPP Bureau - October 20, 2023
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Daiichi Sankyo, Merck collaborate to develop and commercialize three Daiichi Sankyo DXd ADCs
By IPP Bureau - October 20, 2023
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
